Petlife Pharmaceuticals, Inc.
PTLF · OTC
8/31/2017 | 8/31/2016 | 8/31/2015 | 8/31/2014 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54 | $1 | $0 | $7 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $5 | $11 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $0 | $0 | $0 |
| Total Curr. Assets | $55 | $1 | $5 | $17 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $1 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $1 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $55 | $1 | $5 | $17 |
| Liabilities | – | – | – | – |
| Payables | $377 | $758 | $235 | $0 |
| Short-Term Debt | $717 | $153 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $342 | $2,325 | $135 | $0 |
| Total Curr. Liab. | $1,436 | $3,236 | $371 | $0 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,436 | $3,236 | $371 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $3 | $0 | $0 | $0 |
| Common Stock | $74 | $8 | $12 | $55 |
| Retained Earnings | -$30,388 | -$7,131 | -$3,444 | -$1,512 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $28,930 | $3,888 | $3,067 | $1,475 |
| Total Equity | -$1,381 | -$3,235 | -$365 | $17 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $55 | $1 | $5 | $17 |
| Net Debt | $663 | $152 | $0 | -$7 |